There have been a large number of observational studies on the impact of nutrition on neuroprotection, however, there was a lack of evidence from randomized clinical trials (RCTs). In the present systematic review, from the 32 included RCTs published in the last four years (2014–2017) in patients aged 60 years and older with different late-life cognitive disorders, nutritional intervention through medical food/nutraceutical supplementation and multidomain approach improved magnetic resonance imaging findings and other cognitive-related biomarkers, but without clear effect on cognition in mild Alzheimer's disease (AD) and mild cognitive impairment (MCI). Antioxidant-rich foods (nuts, grapes, cherries) and fatty acid supplementation, mainly n-3 polyunsaturated fatty acids (PUFA), improved specific cognitive domains and cognitive-related outcomes in MCI, mild-to-moderate dementia, and AD. Antioxidant vitamin and trace element supplementations improved only cognitive-related outcomes and biomarkers, high-dose B vitamin supplementation in AD and MCI patients improved cognitive outcomes in the subjects with a high baseline plasma n-3 PUFA, while folic acid supplementation had positive impact on specific cognitive domains in those with high homocysteine.

Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders : a systematic review / V. Solfrizzi, P. Agosti, M. Lozupone, C. Custodero, A. Schilardi, V. Valiani, A. Santamato, R. Sardone, V. Dibello, L. Di Lena, R. Stallone, M. Ranieri, A. Bellomo, A. Greco, A. Daniele, D. Seripa, C. Sabbà, G. Logroscino, F. Panza. - In: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. - ISSN 0149-7634. - 95(2018), pp. 480-498. [10.1016/j.neubiorev.2018.10.022]

Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders : a systematic review

P. Agosti;
2018

Abstract

There have been a large number of observational studies on the impact of nutrition on neuroprotection, however, there was a lack of evidence from randomized clinical trials (RCTs). In the present systematic review, from the 32 included RCTs published in the last four years (2014–2017) in patients aged 60 years and older with different late-life cognitive disorders, nutritional intervention through medical food/nutraceutical supplementation and multidomain approach improved magnetic resonance imaging findings and other cognitive-related biomarkers, but without clear effect on cognition in mild Alzheimer's disease (AD) and mild cognitive impairment (MCI). Antioxidant-rich foods (nuts, grapes, cherries) and fatty acid supplementation, mainly n-3 polyunsaturated fatty acids (PUFA), improved specific cognitive domains and cognitive-related outcomes in MCI, mild-to-moderate dementia, and AD. Antioxidant vitamin and trace element supplementations improved only cognitive-related outcomes and biomarkers, high-dose B vitamin supplementation in AD and MCI patients improved cognitive outcomes in the subjects with a high baseline plasma n-3 PUFA, while folic acid supplementation had positive impact on specific cognitive domains in those with high homocysteine.
Alzheimer's disease; Dementia; Macronutrients; Medical food; Micronutrients; Nutraceuticals; Aged; Aged, 80 and over; Cognition Disorders; Dietary Supplements; Humans; Middle Aged; Randomized Controlled Trials as Topic; Neuropsychology and Physiological Psychology; Cognitive Neuroscience; Behavioral Neuroscience
Settore MED/09 - Medicina Interna
Settore MED/26 - Neurologia
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0149763418305074-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 789.96 kB
Formato Adobe PDF
789.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/625299
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 21
social impact